The Brain Charity partners with ITN Business to release news-style programme ‘Inside Neurology: Our Unique Brain’.
It is estimated that one in six people in the UK are affected by a neurological condition of some description, totalling over ten million people. Although those newly diagnosed with neurological conditions can face loneliness and social isolation, there is increased social recognition of the positives of neurodiversity.
To raise awareness of the positive impact of work taking place in this space and the technological innovations and research around brain conditions, The Brain Charity have partnered with ITN Business to produce ‘Inside Neurology: Our Unique Brain’.
Anchored by presenter, Civil Engineer and leading keynote speaker, Ayo Sokale from the ITN London studio, ‘Inside Neurology: Our Unique Brain’ will showcase the unique capabilities of neurodiverse individuals, featuring stories of inclusion, acceptance and empowerment, and will showcase the potential and unique abilities that neurodiverse individuals bring to the workplace and society at large. Additionally, highlighting the cutting-edge research and innovative treatments that are transforming the lives of those with brain injuries.
The programme will explore pertinent themes including:
- Empowering individuals with neurodiverse conditions by highlighting their unique capabilities and positive role models within the community, in addition to strategies for personal and professional thriving
- Technology and innovation within the sector including the advancement in stem cell technologies, MRI and CT imaging and new methods of diagnosis and treatment
- Exploring the relationship between lifestyle choices and neurological health
Launching at the end of 2023, ‘Inside Neurology; Our Unique Brain’ will feature sponsored editorial profiles from organisations, studio interviews with representatives of The Brain Charity and a news item spotlighting the impact of the amazing work done by The Brain Charity.
The programme will also look at the challenges faced by people with conditions like Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, and stroke, among others. The programme will demonstrate the work being done in healthcare and science to improve clinical outcomes for individuals living with these conditions.